Also from this source

You just read:

Shire Reports Positive Efficacy and Safety Results From FAST-3 Study of FIRAZYR(R) (icatibant) for Acute Attacks of Hereditary Angioedema

News provided by

Shire plc

Dec 01, 2010, 07:00 EST